[Nosocomial infections due to rotavirus and respiratory syncytial virus in pediatric wards: a 2-year study]
- PMID: 11022103
[Nosocomial infections due to rotavirus and respiratory syncytial virus in pediatric wards: a 2-year study]
Abstract
Rotavirus and respiratory syncytial virus (RSV) infections represent up to 30% of the totality of nosocomial infections in paediatric wards. We studied the importance of these infections in the paediatric wards of the University Hospital Center of Poitiers, France, from October 1996 to September 1998. We defined as nosocomial an infection acquired after 3 days of hospitalization for rotavirus and after 7 days for RSV. The 274 cases of children presenting rotavirus gastroenteritis or RSV infection within this period were studied. Rotavirus was detected in stools by using an agglutination test and RSV was diagnosed in nasopharyngeal aspirations by direct examination with an immunofluorescence assay (IFA), cell culture and serotyping with IFA. We noted 50 rotavirus and 224 RSV infections, with a first epidemic of RSV subgroup B (49.5%) and a second epidemic of subgroup A (44.9%). 19 (38%) were rotavirus nosocomial infections and 5 (2.2%) were RSV nosocomial infections. The majority of the nosocomial infections occurred before the age of one year and particularly before the age of 6 months (42.2% for rotavirus, 60% for RSV). In comparison to community-acquired infections, children with rotavirus nosocomial infections were younger (9 months versus 12.5 months) which was the opposite for RSV nosocomial infections (10.8 months versus 6.5 months). The sex-ratio of children with community-acquired infections was 2.1 that was not reported in nosocomial infections. The length of stay in hospital was always longer in nosocomial infections (11.7 days versus 3.6 days for rotavirus; 38.8 days versus 4.8 days for RSV). Diarrhea (p = 0.007) and vomiting (p = 0.013) for enteric infections and wheezing (p = 0.02) for respiratory infections were more often observed in community-acquired infections. This study emphasizes the frequency and the consequences of rotavirus and RSV nosocomial infections in paediatric wards and the importance of the hygienic rules to prevent these infections.
Similar articles
-
[Low incidence of nosocomial respiratory syncytial virus infections among children younger than 12 months in the Department of Pediatrics, Sophia Children's Hospital at Rotterdam].Ned Tijdschr Geneeskd. 2000 Jan 1;144(1):24-7. Ned Tijdschr Geneeskd. 2000. PMID: 10665300 Dutch.
-
Importance of nosocomial respiratory syncytial virus infections in an African setting.Trop Med Int Health. 2004 Apr;9(4):491-8. doi: 10.1111/j.1365-3156.2004.01221.x. Trop Med Int Health. 2004. PMID: 15078268
-
[Nosocomial viral infections in a pediatric service: example of rotaviral gastroenteritis and respiratory syncytial viral bronchiolitis].Arch Pediatr. 2004 Aug;11(8):908-15. doi: 10.1016/j.arcped.2004.04.022. Arch Pediatr. 2004. PMID: 15288080 French.
-
[Nosocomial virus infections in pediatric departments. Rotavirus and respiratory syncytial virus].Ugeskr Laeger. 1991 Jul 22;153(30):2102-4. Ugeskr Laeger. 1991. PMID: 1866810 Review. Danish.
-
[Epidemiology of viral nosocomial infections in pediatrics].Pathol Biol (Paris). 2000 Dec;48(10):885-92. Pathol Biol (Paris). 2000. PMID: 11204919 Review. French.
Cited by
-
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.BMC Infect Dis. 2012 Mar 19;12:62. doi: 10.1186/1471-2334-12-62. BMC Infect Dis. 2012. PMID: 22429601 Free PMC article.
-
Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.Drugs. 2010 Jun 18;70(9):1165-88. doi: 10.2165/11205030-000000000-00000. Drugs. 2010. PMID: 20518582 Review.
-
Modeling nosocomial transmission of rotavirus in pediatric wards.Bull Math Biol. 2011 Jul;73(7):1413-42. doi: 10.1007/s11538-010-9570-z. Epub 2010 Sep 1. Bull Math Biol. 2011. PMID: 20811781 Free PMC article.
-
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.Pharmacoeconomics. 2011 May;29(5):439-54. doi: 10.2165/11207130-000000000-00000. Pharmacoeconomics. 2011. PMID: 21504245 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical